 | • レポートコード：QYR2104Z0872 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、膀胱がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（移行上皮がん、浸潤性膀胱がん、表在性膀胱がん、扁平上皮がん、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・膀胱がん治療の市場動向 ・企業の競争状況、市場シェア ・膀胱がん治療の種類別市場規模（移行上皮がん、浸潤性膀胱がん、表在性膀胱がん、扁平上皮がん、その他） ・膀胱がん治療の用途別市場規模（病院、クリニック、その他） ・膀胱がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・膀胱がん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・膀胱がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・膀胱がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・膀胱がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bristol-Myers Squibb、Eli Lilly、F. Hoffman-La Roche、Pfizer） ・結論 |
The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the innermost layer called urothelium or transitional epithelium, composed of epithelium or transitional cells.
The availability of targeted therapy will be one of the major factors driving the growth prospects for the market until the end of 2021. The advancements in drug targeting techniques have enabled doctors to administer drugs directly into the bladder having tumors. This in turn, will help in avoiding side effects of these drugs on healthy cells. With a better understanding of tumor immunology scientists can also now develop new drugs targeted at cancer cells. TECENTRIQ and OPDIVO are the PD-L1 inhibitors recently approved by the US FDA for the treatment of urothelial carcinoma. One of the effective procedures for the diagnosis of bladder cancer, cystoscopy, involves the use of a long thin tube called cystoscope. This helps the urologist to extract a small piece of the abnormal tissue and send it to the pathologists for examination. With the emergence of effective diagnostic tools such as flexible cystoscope, urologists will prefer cystoscopy since it can be easily performed in the outpatient department. This emergence of effective diagnostic tools will be one of the major trends that will gain traction in the bladder cancer therapeutics market during the next four years.
Market Analysis and Insights: Global Bladder Cancer Therapeutics Market
The global Bladder Cancer Therapeutics market size is projected to reach US$ 3988.6 million by 2026, from US$ 3147.5 million in 2019, at a CAGR of 3.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bladder Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bladder Cancer Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bladder Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bladder Cancer Therapeutics market.
Global Bladder Cancer Therapeutics Scope and Market Size
Bladder Cancer Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bladder Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Transitional Cell Bladder Cancer
Invasive Bladder Cancer
Superficial Bladder Cancer
Squamous Cell Bladder Cancer
Others
Segment by Application
Hospitals
Clinics
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bristol-Myers Squibb
Eli Lilly
F. Hoffman-La Roche
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bladder Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Transitional Cell Bladder Cancer
1.2.3 Invasive Bladder Cancer
1.2.4 Superficial Bladder Cancer
1.2.5 Squamous Cell Bladder Cancer
1.2.6 Others
1.3 Market by Application
1.3.1 Global Bladder Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bladder Cancer Therapeutics Market Perspective (2016-2027)
2.2 Bladder Cancer Therapeutics Growth Trends by Regions
2.2.1 Bladder Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bladder Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Bladder Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Bladder Cancer Therapeutics Industry Dynamic
2.3.1 Bladder Cancer Therapeutics Market Trends
2.3.2 Bladder Cancer Therapeutics Market Drivers
2.3.3 Bladder Cancer Therapeutics Market Challenges
2.3.4 Bladder Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bladder Cancer Therapeutics Players by Revenue
3.1.1 Global Top Bladder Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Bladder Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Bladder Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bladder Cancer Therapeutics Revenue
3.4 Global Bladder Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Bladder Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bladder Cancer Therapeutics Revenue in 2020
3.5 Bladder Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Bladder Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Bladder Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bladder Cancer Therapeutics Breakdown Data by Type
4.1 Global Bladder Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Bladder Cancer Therapeutics Forecasted Market Size by Type (2022-2027)
5 Bladder Cancer Therapeutics Breakdown Data by Application
5.1 Global Bladder Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Bladder Cancer Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bladder Cancer Therapeutics Market Size (2016-2027)
6.2 North America Bladder Cancer Therapeutics Market Size by Type
6.2.1 North America Bladder Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Bladder Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Bladder Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Bladder Cancer Therapeutics Market Size by Application
6.3.1 North America Bladder Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Bladder Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Bladder Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Bladder Cancer Therapeutics Market Size by Country
6.4.1 North America Bladder Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Bladder Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Bladder Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Bladder Cancer Therapeutics Market Size by Type
7.2.1 Europe Bladder Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Bladder Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Bladder Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Bladder Cancer Therapeutics Market Size by Application
7.3.1 Europe Bladder Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Bladder Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Bladder Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Bladder Cancer Therapeutics Market Size by Country
7.4.1 Europe Bladder Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Bladder Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bladder Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Bladder Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Bladder Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bladder Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bladder Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Bladder Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Bladder Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bladder Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bladder Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Bladder Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Bladder Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bladder Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bladder Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Bladder Cancer Therapeutics Market Size by Type
9.2.1 Latin America Bladder Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Bladder Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Bladder Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Bladder Cancer Therapeutics Market Size by Application
9.3.1 Latin America Bladder Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Bladder Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Bladder Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Bladder Cancer Therapeutics Market Size by Country
9.4.1 Latin America Bladder Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Bladder Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bladder Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Bladder Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Bladder Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bladder Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bladder Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Bladder Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Bladder Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bladder Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bladder Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Bladder Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Bladder Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bladder Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Bladder Cancer Therapeutics Introduction
11.1.4 Bristol-Myers Squibb Revenue in Bladder Cancer Therapeutics Business (2016-2021)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Bladder Cancer Therapeutics Introduction
11.2.4 Eli Lilly Revenue in Bladder Cancer Therapeutics Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 F. Hoffman-La Roche
11.3.1 F. Hoffman-La Roche Company Details
11.3.2 F. Hoffman-La Roche Business Overview
11.3.3 F. Hoffman-La Roche Bladder Cancer Therapeutics Introduction
11.3.4 F. Hoffman-La Roche Revenue in Bladder Cancer Therapeutics Business (2016-2021)
11.3.5 F. Hoffman-La Roche Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Bladder Cancer Therapeutics Introduction
11.4.4 Pfizer Revenue in Bladder Cancer Therapeutics Business (2016-2021)
11.4.5 Pfizer Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Bladder Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Transitional Cell Bladder Cancer
Table 3. Key Players of Invasive Bladder Cancer
Table 4. Key Players of Superficial Bladder Cancer
Table 5. Key Players of Squamous Cell Bladder Cancer
Table 6. Key Players of Others
Table 7. Global Bladder Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Bladder Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Bladder Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Bladder Cancer Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Bladder Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Bladder Cancer Therapeutics Market Share by Regions (2022-2027)
Table 13. Bladder Cancer Therapeutics Market Trends
Table 14. Bladder Cancer Therapeutics Market Drivers
Table 15. Bladder Cancer Therapeutics Market Challenges
Table 16. Bladder Cancer Therapeutics Market Restraints
Table 17. Global Bladder Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Bladder Cancer Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Bladder Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bladder Cancer Therapeutics as of 2020)
Table 20. Ranking of Global Top Bladder Cancer Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Bladder Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Bladder Cancer Therapeutics Product Solution and Service
Table 24. Date of Enter into Bladder Cancer Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Bladder Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Bladder Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Bladder Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Bladder Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Bladder Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Bladder Cancer Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Bladder Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Bladder Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Bladder Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Bladder Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Bladder Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Bladder Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Bladder Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Bladder Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Bladder Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Bladder Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Bladder Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Bladder Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Bladder Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Bladder Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Bladder Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Bladder Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Bladder Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Bladder Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Bladder Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Bladder Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Bladder Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Bladder Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Bladder Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Bladder Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Bladder Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Bladder Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Bladder Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Bladder Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Bladder Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Bladder Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Bladder Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Bladder Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Bristol-Myers Squibb Company Details
Table 65. Bristol-Myers Squibb Business Overview
Table 66. Bristol-Myers Squibb Bladder Cancer Therapeutics Product
Table 67. Bristol-Myers Squibb Revenue in Bladder Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Bristol-Myers Squibb Recent Development
Table 69. Eli Lilly Company Details
Table 70. Eli Lilly Business Overview
Table 71. Eli Lilly Bladder Cancer Therapeutics Product
Table 72. Eli Lilly Revenue in Bladder Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Eli Lilly Recent Development
Table 74. F. Hoffman-La Roche Company Details
Table 75. F. Hoffman-La Roche Business Overview
Table 76. F. Hoffman-La Roche Bladder Cancer Therapeutics Product
Table 77. F. Hoffman-La Roche Revenue in Bladder Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 78. F. Hoffman-La Roche Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Bladder Cancer Therapeutics Product
Table 82. Pfizer Revenue in Bladder Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Pfizer Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bladder Cancer Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Transitional Cell Bladder Cancer Features
Figure 3. Invasive Bladder Cancer Features
Figure 4. Superficial Bladder Cancer Features
Figure 5. Squamous Cell Bladder Cancer Features
Figure 6. Others Features
Figure 7. Global Bladder Cancer Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Bladder Cancer Therapeutics Report Years Considered
Figure 12. Global Bladder Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Bladder Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Bladder Cancer Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Bladder Cancer Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Bladder Cancer Therapeutics Market Share by Players in 2020
Figure 17. Global Top Bladder Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bladder Cancer Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Bladder Cancer Therapeutics Revenue in 2020
Figure 19. Global Bladder Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Bladder Cancer Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Bladder Cancer Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Bladder Cancer Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Bladder Cancer Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Bladder Cancer Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Bladder Cancer Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Bladder Cancer Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Bladder Cancer Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Bladder Cancer Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Bladder Cancer Therapeutics Market Share by Region (2016-2027)
Figure 41. China Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Bladder Cancer Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Bladder Cancer Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Bladder Cancer Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Bladder Cancer Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Bladder Cancer Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Bladder Cancer Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Bladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Bladder Cancer Therapeutics Business (2016-2021)
Figure 61. Eli Lilly Revenue Growth Rate in Bladder Cancer Therapeutics Business (2016-2021)
Figure 62. F. Hoffman-La Roche Revenue Growth Rate in Bladder Cancer Therapeutics Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Bladder Cancer Therapeutics Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
世界の膀胱がん治療・診断市場規模・現状・予測（2021年-2027年） The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the inner…- 世界の移行細胞がん治療薬市場規模・現状・予測（2021年-2027年） Transitional cell carcinoma (TCC) occur in the different parts of urinary tract, which include kidney, bladder, or urethra. Market revenue drivers for the transitional cell cancer therapeutics market include increase in environmental pollution levels coupled with high rates of cigarette smoking. Mar…
- 世界の過活動膀胱治療薬市場規模・現状・予測（2021年-2027年） Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). North America is the largest consumption market of Overactive …
- 世界の移行上皮がん治療薬市場 2021：企業別、地域別、種類・用途別 The Transitional Cell Cancer Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 世界の扁平上皮非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Squamous Non-Small Cell Lung Cancer Therapeutics Market The global Squamous Non-Small Cell Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard ac…